The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
History of antimicrobial drug discovery: Major classes and health impact
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Fleming, A. (1929) · PubMed Central · Cited by 1,647
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Self-citationβ-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
The IUPAC Compendium of Chemical Terminology: The Gold Book
(2025) · International Union of Pure and Applied Chemistry (IUPAC) eBooks · doi:10.1351/goldbook · Cited by 1,382
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
History of the Use of Antibiotic as Growth Promoters in European Poultry Feeds
Castanon, J. I. R. (2007) · Poultry Science · doi:10.3382/ps.2007-00249 · Cited by 1,256
A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential
Landers, T. F., Cohen, B., Wittum, T. E., & Larson, E. L. (2012) · Public Health Reports® · doi:10.1177/003335491212700103 · Cited by 1,241
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Department of Health and Human Services
(2002) · Handbook of Research Design & Social Measurement · doi:10.4135/9781412984386.n104 · Cited by 1,032
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935
Trends in Infectious Disease Mortality in the United States During the 20th Century
Armstrong, G. L. (1999) · JAMA · doi:10.1001/jama.281.1.61 · Cited by 875
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
Schwarz, S., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.04.001 · Cited by 800
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
The role of antibiotics and antibiotic resistance in nature
Aminov, R. I. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01972.x · Cited by 687
Self-citationThe Gramicidin A Transmembrane Channel: A Proposed π (L,D) Helix
Urry, D. W. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.3.672 · Cited by 667
Horizontal Gene Exchange in Environmental Microbiota
Aminov, R. I. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00158 · Cited by 644
Self-citationEin Beitrag zur Chemotherapie der bakteriellen Infektionen
Domagk, G. (1935) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1129486 · Cited by 619
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
Velayati, A. A., Masjedi, M. R., Farnia, P., Tabarsi, P., Ghanavi, J., ZiaZarifi, A. H., & Hoffner, S. E. (2009) · Chest · doi:10.1378/chest.08-2427 · Cited by 607
Quinolones: from antibiotics to autoinducers
Heeb, S., Fletcher, M. P., Chhabra, S. R., Diggle, S. P., Williams, P., & Cámara, M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00247.x · Cited by 595
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
RifamycinMode of Action, Resistance, and Biosynthesis
Floss, H. G., & Yu, T.-W. (2005) · Chemical Reviews · doi:10.1021/cr030112j · Cited by 547
Diarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547
Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Evans, M. E., Feola, D. J., & Rapp, R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18426 · Cited by 544
Totally Drug-Resistant Tuberculosis in India
Udwadia, Z. F., Amale, R. A., Ajbani, K. K., & Rodrigues, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir889 · Cited by 527
AUREOMYCIN: A PRODUCT OF THE CONTINUING SEARCH FOR NEW ANTIBIOTICS
Duggar, B. M. (1948) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1948.tb27262.x · Cited by 512
Evolution and ecology of antibiotic resistance genes
Aminov, R. I., & Mackie, R. I. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00757.x · Cited by 510
Self-citationLack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby, S. R., Nord, C. E., & Finch, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01283-1 · Cited by 491
The history of the tetracyclines
Nelson, M. L., & Levy, S. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06354.x · Cited by 468
Ultrashort antibacterial and antifungal lipopeptides
Makovitzki, A., Avrahami, D., & Shai, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606129103 · Cited by 468
Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
Shapiro, D. J., Hicks, L. A., Pavia, A. T., & Hersh, A. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt301 · Cited by 466
Tenson, T., Lovmar, M., & Ehrenberg, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00662-4 · Cited by 461
Linezolid: The First Oxazolidinone Antimicrobial
Moellering, R. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00015 · Cited by 455
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
Bager, F., Madsen, M., Christensen, J., & Aarestrup, F. M. (1997) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(96)01119-1 · Cited by 426
Xu, J., Murphy, S. L., Kochanek, K. D., & Bastian, B. A. (2016) · PubMed · Cited by 425
Oliynyk, M., Samborskyy, M., Lester, J. B., Mironenko, T., Scott, N., Dickens, S., Haydock, S. F., & Leadlay, P. F. (2007) · Nature Biotechnology · doi:10.1038/nbt1297 · Cited by 402
Quinolone Antimicrobial Agents
Neu, H. C. (1992) · Annual Review of Medicine · doi:10.1146/annurev.me.43.020192.002341 · Cited by 400
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
Shigeri, Y., Seal, R. P., & Shimamoto, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.004 · Cited by 391
Evolutionary Implications of Bacterial Polyketide Synthases
Jenke-Kodama, H., Sandmann, A., Müller, R., & Dittmann, E. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi193 · Cited by 364
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2010) · Drugs · doi:10.2165/11534440-000000000-00000 · Cited by 352
Tolerance and Specificity of Polyketide Synthases
Khosla, C., Gokhale, R. S., Jacobsen, J. R., & Cane, D. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.219 · Cited by 338
Linezolid: The First Oxazolidinone Antimicrobial
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00017 · Cited by 328
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components
COCITO, C. G. (1979) · Microbiological Reviews · doi:10.1128/mr.43.2.145-192.1979 · Cited by 327
MCGUIRE, J. M., BUNCH, R. L., ANDERSON, R. C., Boaz, H. E., Flynn, E. H., POWELL, H. M., & SMITH, J. W. (1952) · PubMed · Cited by 326
Development of daptomycin for Gram-positive infections
Tally, F. P., & DeBruin, M. F. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.523 · Cited by 321
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319
History of the Development of Rifampin
Sensi, P. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s402 · Cited by 315
Two New Genera of Nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.
LECHEVALIER, M. P., PRAUSER, H., LABEDA, D. P., & RUAN, J.-S. (1986) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-36-1-29 · Cited by 312
Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species
Dubern, J.-F., & Diggle, S. P. (2008) · Molecular BioSystems · doi:10.1039/b803796p · Cited by 308
Gramicidin S and its use in the Treatment of Infected Wounds
GAUSE, G. F., & BRAZHNIKOVA, M. G. (1944) · Nature · doi:10.1038/154703a0 · Cited by 305
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review
Thomas, C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg254 · Cited by 305
Wehrli, W., & Staehelin, M. (1971) · Bacteriological Reviews · doi:10.1128/br.35.3.290-309.1971 · Cited by 302
Echinocandins: a new class of antifungal
Denning, D. W. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf045 · Cited by 300
A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., & Blanchard, J. S. (2005) · Science · doi:10.1126/science.1110699 · Cited by 291
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283
The development of drugs for treatment of sleeping sickness: a historical review
Steverding, D. (2010) · Parasites & Vectors · doi:10.1186/1756-3305-3-15 · Cited by 274
Chemistry and biology of the polyene macrolide antibiotics.
Hamilton-Miller, J. M. T. (1973) · Bacteriological Reviews · doi:10.1128/mmbr.37.2.166-196.1973 · Cited by 274
Linezolid in vitro: mechanism and antibacterial spectrum
Livermore, D. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg249 · Cited by 269
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering
Baltz, R. H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.02.031 · Cited by 267
Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution
Bollenbach, T. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.05.008 · Cited by 261
The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
Lloyd, N. C., Morgan, H. W., Nicholson, B. K., & Ronimus, R. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461471 · Cited by 256
Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa
Klopper, M., Warren, R. M., Hayes, C., van Pittius, N. C. G., Streicher, E. M., Müller, B., Sirgel, F. A., Chabula-Nxiweni, M., Hoosain, E., Coetzee, G. J., et al. (2013) · Emerging infectious diseases · doi:10.3201/eid1903.120246 · Cited by 251
U.S. Outpatient Antibiotic Prescribing, 2010
Hicks, L. A., Taylor, T. H., & Hunkler, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1212055 · Cited by 247
Potential of old-generation antibiotics to address current need for new antibiotics
Falagas, M. E., Grammatikos, A. P., & Michalopoulos, A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.593 · Cited by 247
Long-Term Low-Dose Administration of Erythromycin to Patients with Diffuse Panbronchiolitis
Nagai, H., Shishido, H., Yoneda, R., Yamaguchi, E., Tamura, A., & Kurashima, A. (1991) · Respiration · doi:10.1159/000195915 · Cited by 245
Outpatient antibiotic prescribing in the United States: 2000 to 2010
Lee, G. C., Reveles, K. R., Attridge, R. T., Lawson, K. A., Mansi, I. A., Lewis, J. S., & Frei, C. R. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-96 · Cited by 231
Jayachandran, S., Lleras-Muney, A., & Smith, K. V. (2010) · American Economic Journal: Applied Economics · doi:10.1257/app.2.2.118 · Cited by 230
[Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis].
Kudoh, S., Uetake, T., Hagiwara, K., Hirayama, M., Hus, L.-H., Kimura, H., & Sugiyama, Y. (1987) · PubMed · Cited by 226
Penicillin Treatment of Early Syphilis—A Preliminary Report
Mahoney, J. F., Arnold, R. C., & Harris, A. (1943) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.33.12.1387 · Cited by 222
First tuberculosis cases in Italy resistant to all tested drugs
Migliori, G. B., De Iaco, G., Besozzi, G., Centis, R., & Cirillo, D. M. (2007) · Weekly releases (1997–2007) · doi:10.2807/esw.12.20.03194-en · Cited by 219
Expression and isolation of antimicrobial small molecules from soil DNA libraries.
MacNeil, I. A., Tiong, C. L., Minor, C., August, P. R., Grossman, T. H., Loiacono, K. A., Lynch, B. A., Phillips, T., Narula, S. S., Sundaramoorthi, R., et al. (2001) · PubMed · Cited by 212
Mechanism of action of the oxazolidinone antibacterial agents
Shinabarger, D. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.8.1195 · Cited by 211
Safety and tolerability of linezolid
French, G. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg253 · Cited by 203
Macrocyclization strategies in polyketide and nonribosomal peptide biosynthesis
Kopp, F., & Marahiel, M. A. (2007) · Natural Product Reports · doi:10.1039/b613652b · Cited by 196
Speer, B. S., Bedzyk, L., & Salyers, A. A. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.1.176-183.1991 · Cited by 195
Tigecycline: First of a New Class of Antimicrobial Agents
Rose, W. E., & Rybak, M. J. (2006) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.8.1099 · Cited by 195
Vital statistics rates in the United States, 1940-1960
Grove, R. D., & Hetzel, A. M. (1968) · U.S. Government Printing Office eBooks · Cited by 191
Comparison of echinocandin antifungals
Eschenauer, G., DePestel, D. D., & Carver, P. L. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.1.71 · Cited by 186
Sepkowitz, K. A., Raffalli, J., Riley, L., Kiehn, T. E., & Armstrong, D. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.180 · Cited by 181
Mitochondrial Toxicity Associated with Linezolid
Soriano, A., Miró, O., & Mensa, J. (2005) · New England Journal of Medicine · doi:10.1056/nejm200511243532123 · Cited by 181
Tetracycline-Labeled Human Bone from Ancient Sudanese Nubia (A.D. 350)
Bassett, E. J., Keith, M. S., Armelagos, G. J., Martin, D. L., & Villanueva, A. R. (1980) · Science · doi:10.1126/science.7001623 · Cited by 180
Hughes, C. C., & Fenical, W. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201001279 · Cited by 178
Glycopeptide Antibiotic Resistance
Pootoolal, J., Neu, J., & Wright, G. D. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091601.142813 · Cited by 177
Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure
Enne, V. I. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh217 · Cited by 171
Harms, J. M., Schlünzen, F., Fucini, P., Bartels, H., & Yonath, A. (2004) · BMC Biology · doi:10.1186/1741-7007-2-4 · Cited by 171
Desjardins, C. A., Cohen, K. A., Munsamy, V., Abeel, T., Maharaj, K., Walker, B. J., Shea, T. P., Almeida, D. V., Manson, A. L., Salazar, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3548 · Cited by 171
Oxazolidinone Antibacterial Agents
Brickner, S. J. (1996) · Current Pharmaceutical Design · doi:10.2174/1381612802666220921173820 · Cited by 171
Quinupristin‐Dalfopristin and Linezolid: Evidence and Opinion
Eliopoulos, G. M. (2003) · Clinical Infectious Diseases · doi:10.1086/367662 · Cited by 169
Wright, A. J. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.3.290 · Cited by 167
Talbot et al. (2006 42:657-68)
(2006) · Clinical Infectious Diseases · doi:10.1086/503200 · Cited by 166
Old and New Glycopeptide Antibiotics: Action and Resistance
Binda, E., Marinelli, F., & Marcone, G. (2014) · Antibiotics · doi:10.3390/antibiotics3040572 · Cited by 164
The Structure of Terramycin1,2
Hochstein, F. A., Stephens, C. R., Conover, L. H., Regna, P. P., Pasternack, R. F., Gordon, P. N., Pilgrim, F. J., Brunings, K. J., & Woodward, R. B. (1953) · Journal of the American Chemical Society · doi:10.1021/ja01118a001 · Cited by 160
Dinos, G., Athanassopoulos, C., Missiri, D., Giannopoulou, P., Vlachogiannis, I., Papadopoulos, G., Papaioannou, D., & Kalpaxis, D. (2016) · Antibiotics · doi:10.3390/antibiotics5020020 · Cited by 158
Antimicrobial use in Chinese swine and broiler poultry production
Krishnasamy, V. P., Otté, J., & Silbergeld, E. K. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0050-y · Cited by 154
Crowley, B. M., & Boger, D. L. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0572912 · Cited by 145
Novel Anti-Infective Compounds from Marine Bacteria
Rahman, H., Austin, B. P., Mitchell, W. J., Morris, P. C., Jamieson, D. J., Adams, D. R., Spragg, A. M., & Schweizer, M. (2010) · Marine Drugs · doi:10.3390/md8030498 · Cited by 141
Quinupristin/dalfopristin: A therapeutic review
Allington, D. R., & Rivey, M. P. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80028-x · Cited by 140
Xie, J. H., Pierce, J. G., James, R. C., Okano, A., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207142h · Cited by 140
Xie, J. H., Okano, A., Pierce, J. G., James, R. C., Stamm, S., Crane, C. M., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja209937s · Cited by 138
Prenner, E. J., Lewis, R. N. A. H., Neuman, K. C., Gruner, S. M., Kondejewski, L. H., Hodges, R. S., & McElhaney, R. N. (1997) · Biochemistry · doi:10.1021/bi962785k · Cited by 136
ANTIBIOTIC SUBSTANCES PRODUCED BY PSEUDOMONAS AERUGINOSA
Hays, E. E., Wells, I. C., Katzman, P. A., Cain, C. K., Jacobs, F. A., Thayer, S. A., Doisy, E. A., Gaby, W. L., Roberts, E. C., MUIR, R. D., et al. (1945) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41580-8 · Cited by 133
Armelagos, G. J. (1969) · Science · doi:10.1126/science.163.3864.255 · Cited by 132
Vancomycin resistance: occurrence, mechanisms and strategies to combat it
Boneca, I. G., & Chiosis, G. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.3.311 · Cited by 131
Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns
Tupin, A., Gualtiéri, M., Roquet, F., Morichaud, Z., Brodolin, K. L., & Léonetti, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.017 · Cited by 130
Barnhill, A. E., Brewer, M. T., & Carlson, S. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00678-12 · Cited by 126
Redesign of Glycopeptide Antibiotics: Back to the Future
James, R. C., Pierce, J. G., Okano, A., Xie, J. H., & Boger, D. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300007j · Cited by 118
Mechanisms of glycopeptide resistance in enterococci
Arthur, M., Reynolds, P. E., Depardieu, F., Evers, S., Dutka‐Malen, S., Quintiliani, R., & Courvalin, P. M. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)80003-x · Cited by 116
Echinocandins in the management of invasive fungal infections, part 1
Morris, M. I., & Villmann, M. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050464.p1 · Cited by 111
Nonclassical Biological Activities of Quinolone Derivatives
Daneshtalab, M., & Ahmed, A. A. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3302n · Cited by 110
Rybak, M. J. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01342.x · Cited by 110
Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii
Napier, B. A., Burd, E. M., Satola, S. W., Cagle, S., Ray, S. M., McGann, P., Pohl, J., Lesho, E. P., & Weiss, D. S. (2013) · mBio · doi:10.1128/mbio.00021-13 · Cited by 108
Tetracycline Resistome of the Organic Pig Gut
Kazimierczak, K. A., Scott, K. P., Kelly, D., & Aminov, R. I. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02206-08 · Cited by 108
Self-citationNelson, M. L., DiNardo, A. R., Jeffery, H., & Armelagos, G. J. (2010) · American Journal of Physical Anthropology · doi:10.1002/ajpa.21340 · Cited by 107
Advanced-generation macrolides: tissue-directed antibiotics
Amsden, G. W. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00410-1 · Cited by 106
Eliakim‐Raz, N., Lador, A., Weissman, Y. L., Elbaz, M., Paul, M., & Leibovici, L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku530 · Cited by 105
Paul Ehrlich: founder of chemotherapy
Kaufmann, S. H. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2582 · Cited by 104
Prosser, G. A., & de Carvalho, L. P. S. (2013) · FEBS Journal · doi:10.1111/febs.12108 · Cited by 101
Fluorochrome labelling in roman period skeletons from dakhleh oasis, Egypt
Cook, M., Molto, E., & Anderson, C. (1989) · American Journal of Physical Anthropology · doi:10.1002/ajpa.1330800202 · Cited by 98
One ring to rule them all: Current trends in combating bacterial resistance to the β‐lactams
King, D. T., Sobhanifar, S., & Strynadka, N. C. J. (2016) · Protein Science · doi:10.1002/pro.2889 · Cited by 96
Giambattista, M. D., Chinali, G., & COCITO, C. G. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.4.485 · Cited by 92
Pournaras, S., Koumaki, V., Spanakis, N., Gennimata, V., & Tsakris, A. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.017 · Cited by 91
A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria
Spanogiannopoulos, P., Waglechner, N., Koteva, K. K., & Wright, G. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402358111 · Cited by 89
Gramicidin D conformation, dynamics and membrane ion transport
Burkhart, B. M., Gassman, R. M., Langs, D. A., Pangborn, W. A., Duax, W. L., & Pletnev, V. Z. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(1999)51:2<129::aid-bip3>3.0.co;2-y · Cited by 84
Okano, A., Nakayama, A., Schammel, A. W., & Boger, D. L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja507009a · Cited by 82
Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies
Marsot, A., Guilhaumou, R., Riff, C., & Blin, O. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0428-x · Cited by 81
Brockmann, H., & Henkel, W. (1951) · Chemische Berichte · doi:10.1002/cber.19510840306 · Cited by 77
Jones, R. N., Kohno, S., Ono, Y., Ross, J. E., & Yanagihara, K. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.001 · Cited by 77
Bertrand, D., Bertrand, S., Neveu, E., & FERNANDES, P. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00840-10 · Cited by 76
Azalides from Azithromycin to New Azalide Derivatives
Mutak, S. (2007) · The Journal of Antibiotics · doi:10.1038/ja.2007.10 · Cited by 75
Bambeke, F. V. (2006) · PubMed · Cited by 73
Quinupristin‐Dalfopristin: An Overview
Delgado, G., Neuhauser, M. M., Bearden, D. T., & Danziger, L. H. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.19.1469.34858 · Cited by 72
Robertson, G. T., Bonventre, E. J., Doyle, T. B., Du, Q., Duncan, L. R., Morris, T. W., Roche, E. D., Yan, D., & Lynch, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01649-07 · Cited by 72
Okano, A., Nakayama, A., Wu, K., Lindsey, E. A., Schammel, A. W., Feng, Y., Collins, K. C., & Boger, D. L. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b01008 · Cited by 69
Rifomycin. XI. taxonomic study on streptomyces mediterranei nov. sp.
Margalith, P., & BERETTA, G. (1960) · Mycopathologia · doi:10.1007/bf02089930 · Cited by 67
Lawrence, P. A. (2002) · Nature · doi:10.1038/415835a · Cited by 62
Accelerating global innovation to address antibacterial resistance: introducing CARB-X
Outterson, K., Rex, J. H., Jinks, T., Jackson, P., Hallinan, J., Karp, S., Hung, D. T., Franceschi, F. J., Merkeley, T. G., Houchens, C. R., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.155 · Cited by 61
Sartor, R. B. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13436 · Cited by 60
Bedin, M., Gaben, A., Saucier, C., & Mešter, J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20010 · Cited by 59
Beyond Vancomycin: The Tail of the Lipoglycopeptides
Klinker, K. P., & Borgert, S. J. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.11.007 · Cited by 59
Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram‐Positive Infections
Roberts, K. D., Sulaiman, R., & Rybak, M. J. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1641 · Cited by 58
Teicoplanin metabolism in humans
Bernareggi, A., Borghi, A., Borgonovi, M., Cavenaghi, L., Ferrari, P., Vékey, K., Zanol, M., & ZERILLI, L. F. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.8.1744 · Cited by 54
Cha, J. Y., Ishiwata, A., & Mobashery, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400666200 · Cited by 54
THE CLASSIC: Penicillin as a Chemotherapeutic Agent
Chain, E. B., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing, J., Sanders, A. G., & Peltier, L. F. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000183429.83168.07 · Cited by 52
Antibiotics: the changing regulatory and pharmaceutical industry paradigm
Bax, R. P., & Green, S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku572 · Cited by 52
Lutz, L., Pereira, D. C., Paiva, R. M., Zavascki, A. P., & Barth, A. L. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-196 · Cited by 50
The methymycin/pikromycin pathway: A model for metabolic diversity in natural product biosynthesis
Kittendorf, J. D., & Sherman, D. H. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.082 · Cited by 49
Vancomycin‐resistant enterococci and use of avoparcin in animal feed: is there a link?
Collignon, P. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb123568.x · Cited by 49
Aminov, R. I. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00241 · Cited by 48
Self-citationMACLEOD, A. J., Ross, H. B., Ozere, R. L., Digout, G., & ROOYENC, V. (1964) · PubMed Central · Cited by 46
Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico
Martinez‐Sandoval, F., Ericsson, C. D., Jiang, Z., Okhuysen, P. C., Meléndez-Romero, J. H., Hernandez, N., Forbes, W. P., Shaw, A. L., Bortey, E. B., & DuPont, H. L. (2010) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2009.00385.x · Cited by 46
The Origins of Antibiotic Resistance
Wright, G. D. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-28951-4_2 · Cited by 45
Antibacterial activity in mice of minocycline, a new tetracycline.
Gs, R. (1966) · PubMed · Cited by 44
Streptomycin, Schatz v. Waksman, and the Balance of Credit for Discovery
Kingston, W. (2004) · Journal of the History of Medicine and Allied Sciences · doi:10.1093/jhmas/jrh091 · Cited by 42
Antimicrobial drugs: chronicle of a twentieth century medical triumph
(2008) · Choice Reviews Online · doi:10.5860/choice.46-2116 · Cited by 42
Macrolides in the treatment of asthma
Good, J. T., Rollins, D. R., & Martin, R. J. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834daff8 · Cited by 37
Thiemann, J. E., Zucco, G., & Pelizza, G. (1969) · Archives of Microbiology · doi:10.1007/bf00409680 · Cited by 36
Modern Medicine and the 20th Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs
Jayachandran, S., Lleras‐Muney, A., & Smith, K. V. (2009) · National Bureau of Economic Research · doi:10.3386/w15089 · Cited by 34
Stoffwechselprodukte von Mikroorganismen
Balerna, M., KELLER‐SCHIERLEIN, W., Martius, C., Wolf, H., & Z�hner, H. (1969) · Archives of Microbiology · doi:10.1007/bf00412210 · Cited by 28
Teicoplanin or vancomycin in the treatment of Gram–positive infections?
Murphy, S., & Pinney, R. J. (1995) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1995.tb00619.x · Cited by 27
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation
Ponziani, F. R., Pecere, S., Lopetuso, L. R., Scaldaferri, F., Cammarota, G., & Gasbarrini, A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1186639 · Cited by 25
Frequency and Demographics of Gentamicin Use
Kushner, B. S., Allen, P. D., & Crane, B. T. (2015) · Otology & Neurotology · doi:10.1097/mao.0000000000000937 · Cited by 24
Horizontal gene transfer in microorganisms
Berlanga, M. (2013) · Estudis Romànics (Institut d'Estudis Catalans) · doi:10.2436/im.v16i1.67281 · Cited by 21
Teicoplanin: A Pharmacoeconomic Evaluation of its Use in the Treatment of Gram-Positive Infections
Spencer, C. M., & Bryson, H. M. (1995) · PharmacoEconomics · doi:10.2165/00019053-199507040-00009 · Cited by 20
ACQUIRED RESISTANCE TO PENICILLIN AND TO NEOARSPHENAMINE IN SPIROCHAETA RECURRENTIS
Rollo, I. M., Williamson, J. S., & Plackett, R. L. (1952) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1952.tb00686.x · Cited by 18
Rifalazil and Other Benzoxazinorifamycins in the Treatment of Chlamydia‐Based Persistent Infections
Rothstein, D. M., van Duzer, J., Sternlicht, A. L., & Gilman, S. C. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200700080 · Cited by 18
Naphthomycin, an antimetabolite of vitamin K_1
Balerna, M. (1969) · Medical Entomology and Zoology · Cited by 18
Double and quadruple tetracycline labeling of bone: Impact of the label itself
Lindsay, R. S., Zhou, H., Cosman, F., Nieves, J. W., & Dempster, D. W. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1818 · Cited by 15
Public Health History Corner Vincenzo Tiberio: a misunderstood researcher
Bucci, R., & Gallì, P. (2011) · Italian Journal of Public Health · doi:10.2427/5688 · Cited by 7
Cited by
The occurrence, distribution and degradation of antibiotics by ionizing radiation: An overview
Wang, J., Zhuan, R., & Chu, L. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2018.07.415 · Cited by 471
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Han, B., He, X.-H., Liu, Y.-Q., He, G., Peng, C., & Li, J.-L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00196a · Cited by 402
Osorio, L. L. D. R., Flórez-López, E., & Grande-Tovar, C. D. (2021) · Molecules · doi:10.3390/molecules26020515 · Cited by 367
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Ribeiro da Cunha, B., Fonseca, L. P., & Calado, C. R. C. (2019) · Antibiotics · doi:10.3390/antibiotics8020045 · Cited by 353
Genus-Wide Assessment of Antibiotic Resistance in Lactobacillus spp
Campedelli, I., Mathur, H., Salvetti, E., Clarke, S., Rea, M. C., Torriani, S., Ross, R. P., Hill, C., & O’Toole, P. W. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01738-18 · Cited by 343
Metadata
- Authors
- Aminov, R.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 133
- Pages
- 4-19
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2529409893
- Cited by
- 296
- References
- 196
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.